Robert Mittendorff
Angel · California
Board director at 5 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Series B, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Mar 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Volastra TherapeuticsMar 13, 2023
- SEC Form D: Nalu MedicalJan 5, 2024
- SEC Form D: Capital RxMar 22, 2024
- SEC Form D: Solve TherapeuticsDec 26, 2024
- SEC Form D: Numerion LabsMar 14, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.